risperidone has been researched along with flupenthixol decanoate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M | 1 |
| Dobmeier, P; Kuhn, K; Scherer, J; Schmaus, W | 1 |
| Frey, S; Juckel, G; Linder, R; Stargardt, T | 1 |
| Asmal, L; Carr, J; Chiliza, B; du Plessis, S; Emsley, R; Kahn, RS; Kidd, M; Malhotra, AK; Vink, M | 1 |
3 trial(s) available for risperidone and flupenthixol decanoate
| Article | Year |
|---|---|
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2004 |
[Incidence of rigor during treatment with flupentixol decanoate in comparison to risperidone].
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Flupenthixol; Haloperidol; Humans; Incidence; Male; Middle Aged; Muscle Rigidity; Neurologic Examination; Prospective Studies; Risperidone | 2004 |
Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Body Mass Index; Brain; Delayed-Action Preparations; Double-Blind Method; Eating; Female; Flupenthixol; Humans; Image Interpretation, Computer-Assisted; Injections, Intramuscular; Magnetic Resonance Imaging; Male; Middle Aged; Risperidone; Schizophrenia; South Africa; Young Adult | 2015 |
1 other study(ies) available for risperidone and flupenthixol decanoate
| Article | Year |
|---|---|
Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data.
Topics: Adult; Antipsychotic Agents; Cost-Benefit Analysis; Delayed-Action Preparations; Female; Flupenthixol; Hospitalization; Humans; Male; Markov Chains; Middle Aged; Models, Econometric; Risperidone; Schizophrenia | 2014 |